chr6-29603590-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001470.4(GABBR1):c.2839G>A(p.Asp947Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000195 in 1,591,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001470.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GABBR1 | NM_001470.4 | c.2839G>A | p.Asp947Asn | missense_variant | 23/23 | ENST00000377034.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GABBR1 | ENST00000377034.9 | c.2839G>A | p.Asp947Asn | missense_variant | 23/23 | 1 | NM_001470.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151810Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000928 AC: 2AN: 215628Hom.: 0 AF XY: 0.0000170 AC XY: 2AN XY: 117430
GnomAD4 exome AF: 0.0000201 AC: 29AN: 1439618Hom.: 0 Cov.: 31 AF XY: 0.0000238 AC XY: 17AN XY: 714486
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151810Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74150
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2022 | The c.2839G>A (p.D947N) alteration is located in exon 23 (coding exon 22) of the GABBR1 gene. This alteration results from a G to A substitution at nucleotide position 2839, causing the aspartic acid (D) at amino acid position 947 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at